Imexpharm Corporation Stock

Equities

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
81,600 VND +4.35% Intraday chart for Imexpharm Corporation +19.68% +58.59%
Sales 2024 * 2,190B 85.41M Sales 2025 * 2,486B 96.95M Capitalization 6,284B 245M
Net income 2024 * 334B 13.05M Net income 2025 * 383B 14.94M EV / Sales 2024 * 2.9 x
Net Debt 2024 * 57B 2.22M Net cash position 2025 * - 0 EV / Sales 2025 * 2.53 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
-
Employees 1,411
Yield 2024 *
-
Yield 2025 *
-
Free-Float 12.55%
More Fundamentals * Assessed data
Dynamic Chart
Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024 CI
Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd. CI
More news
1 day+4.35%
1 week+19.68%
Current month+19.20%
1 month+26.96%
3 months+27.68%
6 months+45.71%
Current year+58.59%
More quotes
1 week
68 636.36
Extreme 68636.3636
83 000.00
1 month
63 272.73
Extreme 63272.7273
83 000.00
Current year
51 363.64
Extreme 51363.6364
83 000.00
1 year
47 363.64
Extreme 47363.6364
83 000.00
3 years
37 662.34
Extreme 37662.3377
83 000.00
5 years
26 073.93
Extreme 26073.9261
83 000.00
10 years
19 128.87
Extreme 19128.8729
83 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 72 83-12-31
Chief Operating Officer 45 03-12-31
Corporate Secretary 41 08-09-30
Members of the board TitleAgeSince
Chief Executive Officer 72 83-12-31
Corporate Officer/Principal 51 98-07-31
Chief Operating Officer 45 03-12-31
More insiders
Date Price Change Volume
24-07-12 81,600 +4.35% 160,000
24-07-11 78,200 +5.55% 207,000
24-07-10 74,091 +1.12% 125,620
24-07-09 73,273 +5.08% 257,620
24-07-08 69,727 +2.27% 125,070

End-of-day quote Ho Chi Minh S.E., July 11, 2024

More quotes
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
81,600 VND
Average target price
68,848 VND
Spread / Average Target
-15.63%
Consensus

Annual profits - Rate of surprise